Table 1. Regulatory status of midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin and venetoclax Drug and indicationRegulatory status Midostaurin (Rydapt) Adult patients with newly diagnosed AML who are FLT3+, as detected by an FDA-approved test, in combination with standard cytarabine and daun...
Common side effects of Mylotarg (gemtuzumab ozogamicin for injection) include: nausea vomiting diarrhea constipation headache dizziness anxiety depression sleep problems (insomnia) fever chills shortness of breath high or low blood pressure high blood sugar, or low blood oxygen (hypoxia) Seek medical ...